FHCRC - 1630.00 - a multi-center pilot study of high-dose immunoablative therapy using cyclophosphamide and anti-thymocyte globulin and followed by autologous or syngeneic peripheral blood stem cell transplantation for patients with refractory systemic lupus erythematosus,
Role: Investigator,
National Institutes of Health/DHHS,
(05/2003 - 05/2004)
Status: Completed